Perbedaan Organon Pharma Indonesia Tbk. dan Platinum Wahab Nusantara Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Platinum Wahab Nusantara Tbk. diperdagangkan di Rp91 (kapitalisasi pasar 296,43 M, volume 24 jam 11,14 jt). Perbedaan utamanya: Platinum Wahab Nusantara Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TGUK | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 296,43 M |
Volume | — | 11,14 jt |
Lot | — | 111,42 rb |
Perputaran | — | 972,2 jt |
Harga Rata-rata | — | 87,26 |
Nilai Transaksi | — | 972,2 jt |
Harga Ekuilibrium Indikatif | — | 91 |
Volume Ekuilibrium Indikatif | — | 47,08 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Platinum Wahab Nusantara Tbk. (the Company) was established based on Deed No. 16 dated June 6, 2018 of Notary Dr. Sugih Haryati, S.H., M.Kn., notary in Kota Tangerang. The Company started its commercial activities since 2018, by operating under the trademarks of "Teguk".
Selengkapnya di halaman TGUK →